Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPS6KA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPP2R2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM200B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYX1C1-CCPG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP85 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC121 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF865 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MERTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MATN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM186A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PATL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on